allulose increase glp 1 Is the New GLP-1 Alternative to Weight Loss Drugs? | Ep 281 — Wits & Weights Secretion of GLP-1 but not

Pollack, A

(), L-, (), ( ), (), ( ), (), ()

5,6 In a 12-week randomized trial, supplementation with 1,200 mg per day of berberine and 600 mg per day of cinnamon significantly reduced fasting blood glucose, HbA1c, and low-density lipoprotein (LDL) levels in patients with type 2 diabetes, without producing significant changes in body weight or BMI

Expected milestones during therapy: Baseline assessment and initial labs Early symptom change (26 weeks) Objective lab improvement (612 weeks) Dose optimization and protocol refinement (3 months) Long-term maintenance or tapering plans (612 months) Expectations While most patients experience progressive symptom relief, some begin to notice changes within 2 to 6 weeks, with measurable reduction in inflammation present by 8 to 12 weeks

Rama Rao, K

For What Purposes Do We Process Your Data